Los Angeles Capital Management LLC Recursion Pharmaceuticals, Inc. Transaction History
Los Angeles Capital Management LLC
- $24.7 Billion
- Q3 2024
A detailed history of Los Angeles Capital Management LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 32,755 shares of RXRX stock, worth $245,334. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,755
Previous 32,755
-0.0%
Holding current value
$245,334
Previous $245,000
12.24%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RXRX
# of Institutions
286Shares Held
242MCall Options Held
1.35MPut Options Held
2.32M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl32.8MShares$245 Million2.05% of portfolio
-
Baillie Gifford & CO25.2MShares$189 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA24.3MShares$182 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$130 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA15.4MShares$115 Million1.41% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $1.35B
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...